Author

M. D. Kornberg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

P. A. Wender· 2 shared P. M. Kim· 2 shared A. Shimizu· 1 shared C. Hardman· 1 shared E. Abramson· 1 shared J. J. Lee· 1 shared L. D. Hester· 1 shared P. Gharibani· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

P. A. Wender

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

TPPB modulates PKC activity to attenuate neuroinflammation and ameliorate experimental multiple sclerosis

S. Shanmukha, W. H. Godfrey, P. Gharibani, J. J. Lee, Y. Guo, X. Deng, P. A. Wender, M. D. Kornberg, P. M. Kim

This study shows TPPB, a new PKC modulator, reduces neuroinflammation and promotes CNS repair in experimental MS by targeting innate immune cells.

bioRxiv · Feb 2, 2024Immunology

Designed PKC-targeting bryostatin analogs modulate innate immunity and neuroinflammation

E. Abramson, C. Hardman, A. Shimizu, S. Hwang, L. D. Hester, S. H. Snyder, P. A. Wender, P. M. Kim, M. D. Kornberg

The paper shows that bryologs, synthetic analogs of bryostatin-1, reduce neuroinflammation by targeting PKC in innate immune cells, suggesting their potential as therapeutic agents for neuroinflammatory diseases.

bioRxiv · Sep 12, 2020Immunology